Farms.com Home   News

High Liner Foods Delivers Fourth Consecutive Year of Annual Adjusted EBITDA Growth

LUNENBURG, NS,- High Liner Foods Incorporated (TSX: HLF) ("High Liner Foods" or "the Company"), a leading North American value-added frozen seafood company, today announced financial results for the fifty-two weeks ended December 31, 2022.

"We ended the year with another solid quarter of earnings, including higher sales, gross profit and Adjusted EBITDA, supporting our delivery of the fourth consecutive year of Adjusted EBITDA growth," said Rod Hepponstall, President and Chief Executive Officer of High Liner Foods. "This is a tremendous result that stands out in our corporate history and reflects the significant transformation of our business and the talent and hard work of our team."

"Our success during 2022 and in the fourth quarter was driven by strong operational performance, ongoing business improvements, efficiencies, investment in inventory and in key customer, supplier and distributor relationships. This strengthened our ability to deliver solutions for our customers and consumers based on quality, convenience and value and helped further our competitive positioning in the market."

Mr. Hepponstall, added, "In the year ahead, we will continue to execute against our branded and value-added strategy to innovate across our portfolio and inspire innovation in the category."

Key financial results, reported in U.S. dollars ("USD"), for the fifty-two weeks ended December 31, 2022, or Fiscal 2022, are as follows (unless otherwise noted, all comparisons are relative to the fifty-two weeks ended January 1, 2022, or "Fiscal 2021"):

Click here to see more...

Trending Video

Genetics Behind Swine Resilience - Dr. Jenelle Dunkelberger

Video: Genetics Behind Swine Resilience - Dr. Jenelle Dunkelberger


In this episode of The Swine it Podcast Show Canada, Dr. Jenelle Dunkelberger, geneticist at Topigs Norsvin, explains how genetics can improve disease resilience in pigs. She explores how resilience differs from resistance, the role of genetic variation, and how breeding strategies can enhance health and performance under disease pressure. Dr. Dunkelberger also covers practical applications and future implications for swine production. Listen now on all major platforms!

"Controlled experimental trials confirm that differences in mortality and performance under disease pressure are linked to genetic background, even when environmental conditions remain consistent."

Meet the guest: Dr. Jenelle Dunkelberger / jenelle-dunkelberger-9200ab86 is a geneticist at Topigs Norsvin, where she leads the Global Health and Behavior Research Platform. She earned her PhD from Iowa State University, focusing on host genetics and disease response in pigs. Her work centers on improving swine health and performance through genetic selection for resilience and behavior traits.